Torticollis – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 11:16:05 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Torticollis – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on IPN10200 for Treating Cervical Dystonia in Adults https://clinicaltrials.eu/trial/study-on-ipn10200-for-treating-cervical-dystonia-in-adults/ Mon, 04 May 2026 08:02:42 +0000 https://clinicaltrials.eu/trial/study-on-ipn10200-for-treating-cervical-dystonia-in-adults/ This clinical trial is focused on studying a condition known as Cervical Dystonia, which affects the muscles in the neck, causing involuntary contractions and abnormal movements or postures. The study is testing a new treatment called IPN10200, which is a solution for injection containing a substance known as Clostridium botulinum, neurotoxin serotype A/B. This treatment is being compared to a placebo to see how effective it is in reducing the symptoms of cervical dystonia.

The purpose of the study is to evaluate how well IPN10200 works in reducing the symptoms of cervical dystonia in adults. Participants in the study will receive either the IPN10200 injection or a placebo. The study will monitor changes in symptoms over time, with a particular focus on the first four weeks after treatment. Participants will be assessed at various points up to 36 weeks to track any changes in their condition and to monitor for any side effects.

Throughout the study, participants will be asked to report on their symptoms, including pain levels and how the condition affects their daily activities. The study will also look at how quickly participants experience relief from symptoms and how long the effects of the treatment last. Safety will be closely monitored, including any potential side effects or changes in health status. The goal is to gather comprehensive information on the effectiveness and safety of IPN10200 as a treatment option for cervical dystonia.

]]> Study on the Effectiveness of Botulinum Toxin Type A for Patients with Cervical Dystonia and Abnormal Muscle Activity https://clinicaltrials.eu/trial/study-on-the-effectiveness-of-botulinum-toxin-type-a-for-patients-with-cervical-dystonia-and-abnormal-muscle-activity/ Wed, 29 Apr 2026 15:00:09 +0000 https://clinicaltrials.eu/trial/study-on-the-effectiveness-of-botulinum-toxin-type-a-for-patients-with-cervical-dystonia-and-abnormal-muscle-activity/ This clinical trial is focused on studying a condition known as cervical dystonia. This is a disorder where there is abnormal muscle activity in the neck area, leading to unusual head positions such as twisting, tilting, and tremors. The primary treatment for cervical dystonia involves injections of botulinum toxin type A, which helps reduce the abnormal muscle activity by temporarily weakening the targeted muscles.

The purpose of this study is to explore the presence of abnormal muscle activity in the back muscles of individuals with cervical dystonia. In the second phase, the study will investigate the effectiveness and possible side effects of botulinum toxin injections in the back muscles for those who show abnormal activity in this area. The study will use different formulations of botulinum toxin, including Botox and Xeomin, which are administered through intramuscular injections. Some participants may receive a placebo as part of the study design.

Participants will undergo a series of assessments to monitor changes in the severity of their dystonia. The study will take place over a period of several months, with regular follow-up visits to evaluate the treatment’s impact and any side effects. The goal is to better understand how botulinum toxin can be used to manage symptoms in patients with cervical dystonia who also have abnormal back muscle activity.

]]>